The Acute Myeloid Leukemia Treatment Market growth trajectory is supported by breakthroughs in molecular biology and precision oncology. The identification of genetic mutations driving AML has enabled the creation of highly specific drugs that improve survival rates. Market growth is also stimulated by the rising elderly population, which accounts for a significant proportion of AML cases. As...